q1 adjusted earnings per share $1.47.
qtrly total sales decreased $0.24 per diluted share, or 0.24 percent.
net interest expense is still expected to be about $75 million for year, and still expect to be approximately 25%.
qtrly organic revenue decreased 1.4 percent.
sees fy 2021 revenue up 30% to over 30%.
qtrly net sales growth of 0.4%.
expects capital expenditures of $150 million to $175 million for full year 2021.
sees restructuring in 2021 to be approximately $20 million.